[An evidence based Iberic-Latin American guideline for acute gastroenteritis management in infants and prescholars]

P Gutiérrez Castrellón1, I Polanco Allué, E Salazar Lindo

  • 1Instituto Nacional de Pediatría, Centro de Análisis de la Evidencia COCHRANE-INPed, Red COCHRANE Mexicana, Ministerio de Salud, México.

Insights

For acute gastroenteritis (AG) in young children, oral rehydration solutions are the primary treatment, offering fewer complications than IV fluids. A normal diet and specific supplements like zinc can aid recovery.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Gastroenterology

Background:

  • Acute gastroenteritis (AG) presents significant morbidity and mortality in infants and preschoolers, particularly in developing nations.
  • Existing treatment guidelines require evidence-based updates to support clinical decision-making for pediatric AG.

Purpose of the Study:

  • To develop an evidence-based document to guide therapeutic decisions for acute gastroenteritis in children under five years old.
  • To provide recommendations for the management of acute gastroenteritis in infants and young children based on systematic literature review and expert consensus.

Main Methods:

  • A systematic literature review was conducted in May 2008.
  • Evidence was graded using Oxford guidelines, and recommendations were refined by Latin American experts.

Main Results:

  • Oral rehydration solutions (ORS) are the cornerstone of AG treatment, demonstrating fewer complications compared to intravenous (IV) fluids.
  • A normal diet is not contraindicated during AG. Racecadotril, zinc, and smectite, along with probiotics like Lactobacillus GG and Saccharomyces boulardii, can be beneficial adjuncts.
  • No other medications are recommended for AG treatment.

Conclusions:

  • Oral rehydration solutions should be the primary treatment for acute gastroenteritis in children.
  • Adjunctive therapies including racecadotril, zinc, smectite, and specific probiotics are recommended alongside ORS for managing pediatric AG.

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...